Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Valdecoxib for Post-Surgical Pain from Laparoscopic Cholecystectomy
NCT00661635Phase 3Completed
- Sponsor
- Pfizer
- Start
- Nov 2002
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial of valdecoxib in Persistent postsurgical pain (PPSP) (3 arms), sponsored by Pfizer. Primary endpoints: Patient's Global Evaluation of Study Medication at Day 3 and Summed Pain Intensity (categorical) through 24 hours. Started Nov 2002; status: completed.
02
Drugs
valdecoxib
03
Conditions
Persistent postsurgical pain (PPSP)
Beyond the preview
Go deeper on NCT00661635.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00661635.